Immunome CFO awarded stock options and RSUs
Immunome Inc. Chief Financial Officer Max Rosett received equity awards of 94,500 employee stock options and 47,250 restricted stock units on July 23, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Immunome Inc. Chief Financial Officer Max Rosett received equity awards of 94,500 employee stock options and 47,250 restricted stock units on July 23, 2026.
The options have a $22.01 exercise price, expire July 22, 2036, and vest 25% on July 23, 2027 with the remainder vesting monthly. The RSUs vest 25% annually on each grant anniversary; after the RSU grant he held 101,287 common shares directly and 94,500 options.
Insider Trade Summary
Grant/Award: 141,750 shares
Grant/Award
2 txns
Insider
Rosett Max
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) F2 | 94,500 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 47,250 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (right to buy) — 94,500 contracts (Direct);
Common Stock — 101,287 shares (Direct)
Footnotes (2)
- F1. Represents the number of shares of the Issuer's common stock ("Common Stock") underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of the RSUs will vest and settle into Common Stock annually on each anniversary of the grant date, subject to the Reporting Person's continuous service through each such vesting date.
- F2. 25% of the shares subject to the options vest on July 23, 2027, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter, subject to the Reporting Person's continuous service through each such vesting date.
Key Figures
Stock options granted: 94,500 shares
Option exercise price: $22.01 per share
Option expiration date: July 22, 2036
+5 more
8 metrics
Stock options granted
94,500 shares
Employee stock options granted to CFO on July 23, 2026
Option exercise price
$22.01 per share
Conversion or exercise price of employee stock options
Option expiration date
July 22, 2036
Expiration date of granted employee stock options
RSUs granted
47,250 shares
Restricted stock units tied to common stock granted July 23, 2026
Shares held after RSU grant
101,287 shares
Total direct common stock holdings following RSU award
RSU annual vesting portion
25%
Portion of RSUs that vest each year on grant-date anniversaries
Initial option vesting
25%
Portion of options vesting on July 23, 2027
Subsequent option vesting
1/36
Fraction of remaining options vesting monthly after initial vest date
Key Terms
restricted stock units (RSUs), contingent right, vest, expiration date
4 terms
restricted stock units (RSUs) financial
"Represents the number of shares of Common Stock underlying restricted stock units (RSUs)."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
contingent right financial
"Each RSU represents the contingent right to receive one share of Common Stock."
vest financial
"25% of the RSUs will vest and settle into Common Stock annually."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
expiration date financial
"25% of the shares subject to the options vest on July 23, 2027, and one-thirty-sixth of the remaining shares subject to the options shall vest every month thereafter."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Immunome Inc. (IMNM) grant to CFO Max Rosett?
Immunome granted CFO Max Rosett 94,500 employee stock options and 47,250 restricted stock units (RSUs) on July 23, 2026. The RSUs convert into common shares upon vesting, while the options allow future share purchases at a fixed exercise price.
What are the vesting terms of the RSUs granted to Immunome (IMNM) CFO?
The RSU grant to the CFO vests 25% each year on the anniversary of the July 23, 2026 grant date. Each RSU represents a contingent right to receive one Immunome common share upon settlement, subject to continued service through each vesting date.
What are the key terms of the stock options granted to Immunome (IMNM) CFO?
The CFO received 94,500 stock options with a $22.01 exercise price, expiring July 22, 2036. 25% of the options vest on July 23, 2027, and one‑thirty‑sixth of the remaining options vests each month thereafter, subject to continued service.
Were the Immunome (IMNM) CFO awards reported under a Rule 10b5-1 plan?
The awards were not reported as made under a Rule 10b5-1 trading plan. The filing’s Rule 10b5-1 checkbox was left unchecked, and no footnote indicates they were granted pursuant to a pre-arranged trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates